| John C Bausher Md Phd | |
|
1020 Anderson Dr Suite 203 Aberdeen WA 98520-1055 | |
| (360) 533-6063 | |
| (360) 533-2204 |
| Full Name | John C Bausher Md Phd |
|---|---|
| Speciality | Family Medicine |
| Location | 1020 Anderson Dr, Aberdeen, Washington |
| Authorized Official Name and Position | Jan Dahl (OFFICE MANAGER) |
| Authorized Official Contact | 3605336063 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| John C Bausher Md Phd 1020 Anderson Dr Suite 203 Aberdeen WA 98520-1055 Ph: (360) 533-6063 | John C Bausher Md Phd 1020 Anderson Dr Suite 203 Aberdeen WA 98520-1055 Ph: (360) 533-6063 |
| NPI Number | 1518006220 |
|---|---|
| Provider Enumeration Date | 02/06/2007 |
| Last Update Date | 01/04/2008 |
| Medicare PECOS PAC ID | 3375674401 |
|---|---|
| Medicare Enrollment ID | O20100706000239 |
News Archive
Novartis announced today that the US Food and Drug Administration has granted priority review for LCZ696, an investigational medicine for the treatment of heart failure with reduced ejection fraction (HFrEF). The designation is intended to accelerate the review of therapies that offer a significant improvement in the safety or effectiveness of the treatment, prevention or diagnosis of a serious condition.
A new report by the Geiger Gibson/RCHN Community Health Foundation Research Collaborative at the George Washington University School of Public Health and Health Services examines the impact of health reform on community health centers and their patients.
No single genetic strain of the widespread Clostridium difficile (C. difficile) bacteria appears to be any more harmful than other strains, according to new research published online today in Infection Control & Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America.
The bacterium that causes Legionnaires' disease remains difficult to track. French researchers have now developed a new technique that should allow living representatives of this dangerous pathogen to be detected much more quickly than with conventional methods. As they report in the journal Angewandte Chemie, samples are exposed to an azide-modified compound that the pathogen specifically incorporates into its shell, which is made of saccharide units. A fluorescent marker attached to the azide groups is used to identify the pathogen.
› Verified 8 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518006220 | NPI | - | NPPES |
| 1097419 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD00017464 (Washington) | Primary |
| Provider Name | John Charles Bausher |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1033207824 PECOS PAC ID: 4284765314 Enrollment ID: I20100706000317 |
News Archive
Novartis announced today that the US Food and Drug Administration has granted priority review for LCZ696, an investigational medicine for the treatment of heart failure with reduced ejection fraction (HFrEF). The designation is intended to accelerate the review of therapies that offer a significant improvement in the safety or effectiveness of the treatment, prevention or diagnosis of a serious condition.
A new report by the Geiger Gibson/RCHN Community Health Foundation Research Collaborative at the George Washington University School of Public Health and Health Services examines the impact of health reform on community health centers and their patients.
No single genetic strain of the widespread Clostridium difficile (C. difficile) bacteria appears to be any more harmful than other strains, according to new research published online today in Infection Control & Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America.
The bacterium that causes Legionnaires' disease remains difficult to track. French researchers have now developed a new technique that should allow living representatives of this dangerous pathogen to be detected much more quickly than with conventional methods. As they report in the journal Angewandte Chemie, samples are exposed to an azide-modified compound that the pathogen specifically incorporates into its shell, which is made of saccharide units. A fluorescent marker attached to the azide groups is used to identify the pathogen.
› Verified 8 days ago
News Archive
Novartis announced today that the US Food and Drug Administration has granted priority review for LCZ696, an investigational medicine for the treatment of heart failure with reduced ejection fraction (HFrEF). The designation is intended to accelerate the review of therapies that offer a significant improvement in the safety or effectiveness of the treatment, prevention or diagnosis of a serious condition.
A new report by the Geiger Gibson/RCHN Community Health Foundation Research Collaborative at the George Washington University School of Public Health and Health Services examines the impact of health reform on community health centers and their patients.
No single genetic strain of the widespread Clostridium difficile (C. difficile) bacteria appears to be any more harmful than other strains, according to new research published online today in Infection Control & Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America.
The bacterium that causes Legionnaires' disease remains difficult to track. French researchers have now developed a new technique that should allow living representatives of this dangerous pathogen to be detected much more quickly than with conventional methods. As they report in the journal Angewandte Chemie, samples are exposed to an azide-modified compound that the pathogen specifically incorporates into its shell, which is made of saccharide units. A fluorescent marker attached to the azide groups is used to identify the pathogen.
› Verified 8 days ago
Timothy H. Troeh, M D P S Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 205 9th Ave, Aberdeen, WA 98520 Phone: 360-589-6982 | |
Hany G Bashandy Md Ps Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1020 Anderson Dr Ste 205, Aberdeen, WA 98520 Phone: 360-533-6038 Fax: 360-538-0807 | |
Kenneth I Hunt Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1006 N H St, Aberdeen, WA 98520 Phone: 360-537-6391 Fax: 360-537-6322 | |
Colette M Kato Pllc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1220 Basich Blvd, Suite A, Aberdeen, WA 98520 Phone: 360-532-1800 Fax: 360-532-2658 | |
Harbor Infectious Diseases Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1730 Graves Ave, Aberdeen, WA 98520 Phone: 360-532-2311 | |
Grays Harbor Vision Clinic, Inc. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 301 N Broadway St, Aberdeen, WA 98520 Phone: 360-533-1880 Fax: 360-533-1886 | |
Coastal Internal Medicine, Pllc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1921 Sumner Avenue, Aberdeen, WA 98520 Phone: 360-538-0135 Fax: 360-533-3475 |